ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,962
Screening encounters
4,681
Diagnostic referrals
898
Outstanding pathways
320

Screening pathway

  1. Screening4,681Encounters
  2. Positive finding1,615Documented findings
  3. Referral898Diagnostic referrals
  4. Follow-up1,070Diagnostic visits
  5. Outcome578Resolved pathways

Stage totals use different units. Pending pathways: 320. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-12-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R
  12. · Surveillance · HPV DNA · Surveillance · After clinical assessment

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3962 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4385 · Expanded synthetic participant 4385Site C — Rural Outreach Programme
EXP-4386 · Expanded synthetic participant 4386Site D — Community Engagement Programme
EXP-4387 · Expanded synthetic participant 4387Site D — Community Engagement Programme
EXP-4388 · Expanded synthetic participant 4388Site B — Peri-Urban Access Programme
EXP-4389 · Expanded synthetic participant 4389Site B — Peri-Urban Access Programme
EXP-4390 · Expanded synthetic participant 4390Site A — Urban Referral Hub
EXP-4391 · Expanded synthetic participant 4391Site A — Urban Referral Hub
EXP-4392 · Expanded synthetic participant 4392Site C — Rural Outreach Programme
EXP-4393 · Expanded synthetic participant 4393Site D — Community Engagement Programme
EXP-4394 · Expanded synthetic participant 4394Site D — Community Engagement Programme
EXP-4396 · Expanded synthetic participant 4396Site E — Resource-Constrained Navigation Programme
EXP-4397 · Expanded synthetic participant 4397Site A — Urban Referral Hub
EXP-4398 · Expanded synthetic participant 4398Site B — Peri-Urban Access Programme
EXP-4399 · Expanded synthetic participant 4399Site B — Peri-Urban Access Programme
EXP-4400 · Expanded synthetic participant 4400Site E — Resource-Constrained Navigation Programme
EXP-4401 · Expanded synthetic participant 4401Site E — Resource-Constrained Navigation Programme
EXP-4402 · Expanded synthetic participant 4402Site A — Urban Referral Hub
EXP-4403 · Expanded synthetic participant 4403Site A — Urban Referral Hub
EXP-4404 · Expanded synthetic participant 4404Site D — Community Engagement Programme
EXP-4405 · Expanded synthetic participant 4405Site B — Peri-Urban Access Programme
EXP-4406 · Expanded synthetic participant 4406Site A — Urban Referral Hub
EXP-4409 · Expanded synthetic participant 4409Site D — Community Engagement Programme
EXP-4410 · Expanded synthetic participant 4410Site C — Rural Outreach Programme
EXP-4411 · Expanded synthetic participant 4411Site B — Peri-Urban Access Programme
EXP-4412 · Expanded synthetic participant 4412Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1784
HPV DNA
2235
Cytology
662

Navigation activity

Barrier documented
798
Contact attempt
1313
Navigation intervention
341
Diagnostic booking
1119
Diagnostic visit
1070

Documented barriers

Contact difficulty
256
Transport difficulty
262
Appointment coordination
280

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.